{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:04:06Z","timestamp":1791597846212,"version":"4.3.4"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jpha.2012.04.006","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T05:45:55Z","timestamp":1335246355000},"page":"390-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Development and validation of RP-HPLC method for estimation of eplerenone in spiked human plasma"],"prefix":"10.1016","volume":"2","author":[{"given":"Paraag","family":"Gide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Sonawane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Chitnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpha.2012.04.006_bib1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1067\/mhj.2002.120775","article-title":"Expanding the outcomes in clinical trils of heart failure: the quality of life and economic components of EPHESUS (eplerenone's neurohormonal efficiency and survival study)","volume":"143","author":"Spetrus","year":"2002","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.jpha.2012.04.006_bib2","first-page":"185","article-title":"Eplerenone: a selective aldosterone receptor antagonist (SARA)","volume":"19","author":"Delyani","year":"2001","journal-title":"Cardiovasc. Ther."},{"issue":"4","key":"10.1016\/j.jpha.2012.04.006_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1556\/AChrom.21.2009.4.8","article-title":"Stability-indicating RP-HPLC method for analysis of eplerenone in the bulk drug and in pharmaceutical dosage form","volume":"21","author":"Rane","year":"2009","journal-title":"Acta Chromatogr."},{"issue":"17","key":"10.1016\/j.jpha.2012.04.006_bib4","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1080\/10826076.2011.582913","article-title":"An experimental design approach for the forced degradation studies and development of a stability-indicating method for eplerenone in tablets","volume":"34","author":"Sonawane","year":"2011","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"issue":"2","key":"10.1016\/j.jpha.2012.04.006_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1570-0232(02)00964-9","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometric assay for eplerenone and its hydrolyzed metabolite in human plasma","volume":"787","author":"Zhang","year":"2003","journal-title":"J. Chromatogr. B"},{"issue":"1","key":"10.1016\/j.jpha.2012.04.006_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0731-7085(02)00595-2","article-title":"A validated SPE\u2013LC\/MS assay for eplerenone and its hydrolyzed metabolite in human urine","volume":"31","author":"Zhang","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpha.2012.04.006_bib7","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation, \u3008http:\/\/www.fda.gov\/cder\/guidance\/index.htm\u3009 (visited on 16.11.11)."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209517791200055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209517791200055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:26:53Z","timestamp":1761859613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S209517791200055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S209517791200055X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2012.04.006","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of RP-HPLC method for estimation of eplerenone in spiked human plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2012.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Xi'an Jiaotong University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}